GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » Total Long-Term Liabilities

Shedir Pharma Group SpA (MIL:SHE) Total Long-Term Liabilities : €4.52 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Shedir Pharma Group SpA's Total Long-Term Liabilities for the quarter that ended in Jun. 2024 was €4.52 Mil.


Shedir Pharma Group SpA Total Long-Term Liabilities Historical Data

The historical data trend for Shedir Pharma Group SpA's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shedir Pharma Group SpA Total Long-Term Liabilities Chart

Shedir Pharma Group SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Get a 7-Day Free Trial 7.94 13.32 10.00 7.44 5.59

Shedir Pharma Group SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.07 7.44 5.92 5.59 4.52

Shedir Pharma Group SpA Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


Shedir Pharma Group SpA Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Shedir Pharma Group SpA's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Shedir Pharma Group SpA Business Description

Traded in Other Exchanges
N/A
Address
95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063
Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.

Shedir Pharma Group SpA Headlines